Jumpei Kashima Yusuke Okuma Tsunekazu Hishima
10.2147/OTT.S112833
Onco Targets Ther
2016 Oct 12;9:6059-6063.
alectinib anaplastic lymphoma kinase rearrangement crizotinib
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/27785052/
Case Reports
PMC5066989
27785052
A patient previously treated with ALK inhibitors for central nervous system lesions from ALK rearranged lung cancer: a case report
2016